Type III interferon drives thymic B cell activation and regulatory T cell generation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36802427.
- Also identified by DOI 10.1073/pnas.2220120120 and PMC identifier 9992806.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The activation of thymic B cells is critical for their licensing as antigen presenting cells and resulting ability to mediate T cell central tolerance. The processes leading to licensing are still not fully understood. By comparing thymic B cells to activated Peyer's patch B cells at steady state, we found that thymic B cell activation starts during the neonatal period and is characterized by TCR/CD40-dependent activation, followed by immunoglobulin class switch recombination (CSR) without forming germinal centers. Transcriptional analysis also demonstrated a strong interferon signature, which was not apparent in the periphery. Thymic B cell activation and CSR were primarily dependent on type III IFN signaling, and loss of type III IFN receptor in thymic B cells resulted in reduced thymocyte regulatory T cell (T<sub>reg</sub>) development. Finally, from TCR deep sequencing, we estimate that licensed B cells induce development of a substantial fraction of the T<sub>reg</sub> cell repertoire. Together, these findings reveal the importance of steady-state type III IFN in generating licensed thymic B cells that induce T cell tolerance to activated B cells.
Medical subject headings
- T-Lymphocytes, Regulatory
- Interferon Lambda